Bahrain – Investcorp, a leading global provider and manager of alternative investment products, today announced that it has signed an agreement to acquire a majority interest in Cambio Healthcare Systems AB (“Cambio” or “the Company”) from Valedo Partners Fund II AB (“Valedo”) and a group of minority investors. Cambio’s founders and management team will continue to hold a meaningful stake in the Company. The transaction remains subject to receipt of customary regulatory approvals.
Cambio operates in the Electronic Health Records (“EHR") market, offering software solutions for acute, primary, social and person-centred care. Cambio promotes a holistic view on health and social care and offers an EHR agnostic solution for clinical decision support applicable for all branches of health and social care. The Company, which has grown rapidly in recent years, has customers primarily in Sweden, Denmark and the United Kingdom, with more than 150,000 users of its software solutions. Cambio is headquartered in Stockholm, Sweden and has approximately 600 employees, of which the majority are dedicated to research and development as well as software maintenance.
Hazem Ben-Gacem, Co-CEO of Investcorp, said: “We see solid growth potential in Cambio Healthcare System, which has already established itself as a strong player in the European region, offering innovative solutions in a promising healthcare market. We look forward to working with Cambio’s management team and using our expertise to build on their success story.”
Yasser Bajsair, Investcorp’s Managing Director in Saudi Arabia, said: “The global healthcare industry is witnessing a digitization overhaul, and an investment in Cambio Healthcare Systems allows our clients to be directly exposed to a successful healthcare digital service provider. This acquisition is another step towards further diversifying our healthcare portfolio across the value chain.”
Peter Gille, CEO, Cambio Healthcare Systems, said; “eHealth is increasingly transforming how healthcare is delivered, and is a key enabler for further improvements of quality of care, productivity and patient empowerment. Cambio is clearly one of the leading providers in the Nordic and UK eHealth markets and I am very proud of our achievements during the last few years. We now look forward to continuing Cambio’s growth journey with the support of Investcorp.”
Investcorp’s previous investments in Nordic technology companies include Abax, a leading developer and supplier of vehicle tracking systems technology in Norway; Coresec, a leading cyber security infrastructure and managed services provider in Sweden; and Asiakastieto, Finland’s leading provider of business and credit information which Investcorp took public on the Helsinki Stock Exchange in 2015.
-Ends-
About Investcorp
Investcorp is a leading global manager of alternative investments. Led by a new vision, Investcorp has embarked on an ambitious, albeit prudent, growth strategy. The Firm continues to focus on generating value through a disciplined investment approach in four lines of business: private equity, real estate, absolute return investments and credit management.
As at June 30, 2018, the Investcorp Group had US$ 22.6 billion in total AUM, including assets managed by third party managers and assets subject to a non-discretionary advisory mandate where Investcorp receives fees calculated on the basis of AUM.
Since its inception in 1982, Investcorp has made over 175 Private Equity deals in the U.S., Europe, the Middle East and North Africa region and Asia, across a range of sectors including retail and consumer products, technology, business services and industrials, and more than 600 commercial and residential real estate investments in the US and Europe, for in excess of US $57 billion in transaction value.
Investcorp employs approximately 400 people across its offices in Bahrain, New York, London, Abu Dhabi, Riyadh, Doha, India, and Singapore. For further information, including our most recent periodic financial statements, which details our assets under management, please refer to: www.investcorp.com
www.linkedin.com/company/Investcorp
About Cambio Healthcare Systems
Cambio Healthcare Systems is one of Scandinavia’s leading suppliers of healthcare information systems and a growing player in the European market with just over 150,000 users across general and university hospitals, specialist units and outpatient units. Through the use of our integrated solutions, our customers provide services to 4 million patients. Since 1993, our ambition has been to combine the continuous development of our technology with the constant improvement of our care processes and eHealth services software support, in order to offer our customers safer and more efficient care support. We are growing continuously and currently have more than 600 employees globally with different backgrounds, skills and responsibilities, but who are all passionate about developing open and comprehensive eHealth solutions tailored towards the publicly-funded healthcare sector. We are geographically close to our customers with offices in Sweden, Denmark, England and Sri Lanka.
About Valedo
Valedo is an independent Swedish investment company investing in high-quality small/mid cap companies in the Nordic region. Valedo is focusing on companies with clear growth and development potential where Valedo can actively contribute to and accelerate the companies’ development. Being an active owner and contributing both capital and industrial experience, Valedo ensures that a company can achieve its full potential.
© Press Release 2019Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
